Thermo Fisher Scientific OX40 Monoclonal Antibody (OX40)

Applications

Tested Dilution

Publications

Immunohistochemistry (Frozen) (IHC (F))

Assay-dependent

-

Flow Cytometry (Flow)

1 µg/1 million cells

View 3 publications 3 publications

Product Specifications

Species Reactivity

Rat

Published species

Cat, Rat

Host/Isotype

Mouse / IgG2b

Class

Monoclonal

Type

Antibody

Clone

OX40

Immunogen

Phytohaemagglutinin-activated rat lymph node cells. if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:OX40 (CD134),uniProtId:P15725-1,ncbiNodeId:10114,antigenRange:1-271,antigenLength:271,antigenImageFileName:MA1-70020_OX40_CD134_P15725-1_House_mouse.svg,antigenImageFileNamePDP:MA1-70020_OX40_CD134_P15725-1_House_mouse_PDP.jpeg,sortOrder:3}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

View additional formats

• Biotin
• FITC
• PE
• Request custom conjugation

Form

Liquid

Concentration

1 mg/mL

Purification

Protein G

Storage buffer

PBS

Contains

0.02% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_1071228

Product Specific Information

MA1-70020 detects CD134 in rat samples.

MA1-70020 has been successfully used in flow cytometry, immunoprecipitation and immunohistochemistry (frozen sections) procedures.

The MA1-70020 immunogen is Phytohaemagglutinin-activated rat lymph node cells.

Target Information

OX40 is a protein receptor found on the surface of T cells, a type of white blood cell that plays a crucial role in the immune system. When activated, OX40 promotes the proliferation and survival of T cells, leading to a stronger immune response against cancer cells and infectious agents. OX40 agonists, which are drugs that activate OX40, have shown promising results in preclinical and clinical studies as a potential immunotherapy for cancer. They can enhance the efficacy of other cancer treatments such as chemotherapy and checkpoint inhibitors, and may also have applications in autoimmune diseases and allergies.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.